While Ku55933 blocked the phosphorylation of ATM, the protein levels of CBP and DOT1L were significantly decreased upon Ku55933 treatment in human MLLr-AML cells (Supplementary Fig. S7H, I). Here, CREBBP is linked to acute myeloid leukemia.